Index by author

September 05, 2014; Volume 9,Issue 9

A

  1. Adragna, Marta

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  2. Aizer, Ayal A.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  3. Akbar, Sana

    1. The Ethics of Offering Dialysis for AKI to the Older Patient: Time to Re-Evaluate?
      Sana Akbar and Alvin H. Moss
      CJASN September 2014, 9 (9) 1652-1656; DOI: https://doi.org/10.2215/CJN.01630214

  4. Akchurin, Oleh M.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  5. Arnold, Robert M.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  6. Avasare, Rupali

    1. Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis
      Jonathan Hogan, Rupali Avasare and Jai Radhakrishnan
      CJASN September 2014, 9 (9) 1657-1667; DOI: https://doi.org/10.2215/CJN.01600214

B

  1. Bagshaw, Sean M.

    1. Timing of RRT Based on the Presence of Conventional Indications
      Suvi T. Vaara, Matti Reinikainen, Ron Wald, Sean M. Bagshaw, Ville Pettilä and The FINNAKI Study Group
      CJASN September 2014, 9 (9) 1577-1585; DOI: https://doi.org/10.2215/CJN.12691213

  2. Bajema, Ingeborg

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  3. Bakker, Stephan J.L.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  4. Berden, Annelies

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  5. Berns, Jeffrey S.

    1. Training the Next Generation’s Nephrology Workforce
      Jeffrey S. Berns, David H. Ellison, Stuart L. Linas and Mitchell H. Rosner
      CJASN September 2014, 9 (9) 1639-1644; DOI: https://doi.org/10.2215/CJN.00560114

  6. Bianchini, Elisa

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  7. Bitran, Daniel

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  8. Boertien, Wendy E.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  9. Brooks, Ellen R.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

C

  1. Campbell, Kirk N.

    1. Can Biomarkers of Disease Activity Guide Treatment in FSGS?
      Kirk N. Campbell and John C. He
      CJASN September 2014, 9 (9) 1507-1509; DOI: https://doi.org/10.2215/CJN.07170714

  2. Chen, Huimei

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  3. Chiodini, Paolo

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  4. Conte, Giuseppe

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  5. Cowgill, Larry D.

    1. Can Oral Therapy Reduce Uremic Toxins?
      Thomas A. Depner and Larry D. Cowgill
      CJASN September 2014, 9 (9) 1513-1515; DOI: https://doi.org/10.2215/CJN.07330714

  6. Coyne, Daniel W.

    1. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD
      Daniel W. Coyne, Seth Goldberg, Mark Faber, Cybele Ghossein and Stuart M. Sprague
      CJASN September 2014, 9 (9) 1620-1626; DOI: https://doi.org/10.2215/CJN.10661013

  7. Cricelli, Claudio

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  8. Cricelli, Iacopo

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  9. Curthoys, Norman P.

    1. Open Access
      Proximal Tubule Function and Response to Acidosis
      Norman P. Curthoys and Orson W. Moe
      CJASN September 2014, 9 (9) 1627-1638; DOI: https://doi.org/10.2215/CJN.10391012

D

  1. de Jong, Paul E.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  2. De Nicola, Luca

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  3. Depner, Thomas A.

    1. Can Oral Therapy Reduce Uremic Toxins?
      Thomas A. Depner and Larry D. Cowgill
      CJASN September 2014, 9 (9) 1513-1515; DOI: https://doi.org/10.2215/CJN.07330714

E

  1. Ellison, David H.

    1. Training the Next Generation’s Nephrology Workforce
      Jeffrey S. Berns, David H. Ellison, Stuart L. Linas and Mitchell H. Rosner
      CJASN September 2014, 9 (9) 1639-1644; DOI: https://doi.org/10.2215/CJN.00560114

F

  1. Faber, Mark

    1. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD
      Daniel W. Coyne, Seth Goldberg, Mark Faber, Cybele Ghossein and Stuart M. Sprague
      CJASN September 2014, 9 (9) 1620-1626; DOI: https://doi.org/10.2215/CJN.10661013

  2. Faurschou, Mikkel

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  3. Fine, Michael J.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  4. Fink, Daniel

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  5. Flossmann, Oliver

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  6. Fox, Chester

    1. Checklists as Computer Decision Support at the Point of Care: A Step Forward in the Recognition and Treatment of CKD by Primary Care Physicians
      Chester Fox and Joseph Vassalotti
      CJASN September 2014, 9 (9) 1505-1506; DOI: https://doi.org/10.2215/CJN.07270714

  7. Franssen, Casper F.M.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  8. Furth, Susan L.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

G

  1. Gansevoort, Ron T.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  2. Gardner, Christopher D.

    1. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
      Tammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter and Timothy W. Meyer
      CJASN September 2014, 9 (9) 1603-1610; DOI: https://doi.org/10.2215/CJN.00490114

  3. Ghossein, Cybele

    1. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD
      Daniel W. Coyne, Seth Goldberg, Mark Faber, Cybele Ghossein and Stuart M. Sprague
      CJASN September 2014, 9 (9) 1620-1626; DOI: https://doi.org/10.2215/CJN.10661013

  4. Goldberg, Seth

    1. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD
      Daniel W. Coyne, Seth Goldberg, Mark Faber, Cybele Ghossein and Stuart M. Sprague
      CJASN September 2014, 9 (9) 1620-1626; DOI: https://doi.org/10.2215/CJN.10661013

  5. Green, Jamie A.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  6. Greenbaum, Larry A.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

H

  1. He, John C.

    1. Can Biomarkers of Disease Activity Guide Treatment in FSGS?
      Kirk N. Campbell and John C. He
      CJASN September 2014, 9 (9) 1507-1509; DOI: https://doi.org/10.2215/CJN.07170714

  2. Heckert, Karl Heinz

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

  3. Hitti, Sharbel

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  4. Hogan, Jonathan

    1. Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis
      Jonathan Hogan, Rupali Avasare and Jai Radhakrishnan
      CJASN September 2014, 9 (9) 1657-1667; DOI: https://doi.org/10.2215/CJN.01600214

  5. Hoglund, Peter

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  6. Hoppe, Bernd

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  7. Hostetter, Thomas H.

    1. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
      Tammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter and Timothy W. Meyer
      CJASN September 2014, 9 (9) 1603-1610; DOI: https://doi.org/10.2215/CJN.00490114

J

  1. Jayne, David R.W.

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  2. Justa Roldan, Maria Luisa

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

K

  1. Kaskel, Frederick J.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

L

  1. Langman, Craig B.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  2. Lapi, Francesco

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  3. Leaf, David E.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  4. Lee, Thomas H.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  5. Li, Limin

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  6. Lifschitz, Meyer

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  7. Linas, Stuart L.

    1. Training the Next Generation’s Nephrology Workforce
      Jeffrey S. Berns, David H. Ellison, Stuart L. Linas and Mitchell H. Rosner
      CJASN September 2014, 9 (9) 1639-1644; DOI: https://doi.org/10.2215/CJN.00560114

  8. Liu, Chunbei

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  9. Liu, Zhihong

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  10. Lopez, Laura

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  11. Lopez Trascasa, Margarita

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

M

  1. Meijer, Esther

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  2. Mendu, Mallika L.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  3. Merin, Ofer

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  4. Meyer, Timothy W.

    1. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
      Tammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter and Timothy W. Meyer
      CJASN September 2014, 9 (9) 1603-1610; DOI: https://doi.org/10.2215/CJN.00490114

  5. Minutolo, Roberto

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  6. Moe, Orson W.

    1. Open Access
      Proximal Tubule Function and Response to Acidosis
      Norman P. Curthoys and Orson W. Moe
      CJASN September 2014, 9 (9) 1627-1638; DOI: https://doi.org/10.2215/CJN.10391012

  7. Mor, Maria K.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  8. Moss, Alvin H.

    1. The Ethics of Offering Dialysis for AKI to the Older Patient: Time to Re-Evaluate?
      Sana Akbar and Alvin H. Moss
      CJASN September 2014, 9 (9) 1652-1656; DOI: https://doi.org/10.2215/CJN.01630214

  9. Moxey-Mims, Marva

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  10. Muller Kobold, Anneke C.

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  11. Mulqueen, Lucy

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

N

  1. Navis, Gerjan

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  2. Nester, Carla M.

    1. Factors Influencing Treatment of Atypical Hemolytic Uremic Syndrome
      Carla M. Nester and Richard J.H. Smith
      CJASN September 2014, 9 (9) 1516-1518; DOI: https://doi.org/10.2215/CJN.07540714

P

  1. Palevsky, Paul M.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  2. Pecchioli, Serena

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  3. Peña, Antonia

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  4. Pettilä, Ville

    1. Timing of RRT Based on the Presence of Conventional Indications
      Suvi T. Vaara, Matti Reinikainen, Ron Wald, Sean M. Bagshaw, Ville Pettilä and The FINNAKI Study Group
      CJASN September 2014, 9 (9) 1577-1585; DOI: https://doi.org/10.2215/CJN.12691213

  5. Piccinocchi, Gaetano

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  6. Pinto, Sheila

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  7. Plummer, Natalie S.

    1. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
      Tammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter and Timothy W. Meyer
      CJASN September 2014, 9 (9) 1603-1610; DOI: https://doi.org/10.2215/CJN.00490114

  8. Pusey, Charles D.

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

R

  1. Radhakrishnan, Jai

    1. Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis
      Jonathan Hogan, Rupali Avasare and Jai Radhakrishnan
      CJASN September 2014, 9 (9) 1657-1667; DOI: https://doi.org/10.2215/CJN.01600214

  2. Reinikainen, Matti

    1. Timing of RRT Based on the Presence of Conventional Indications
      Suvi T. Vaara, Matti Reinikainen, Ron Wald, Sean M. Bagshaw, Ville Pettilä and The FINNAKI Study Group
      CJASN September 2014, 9 (9) 1577-1585; DOI: https://doi.org/10.2215/CJN.12691213

  3. Rodríguez de Córdoba, Santiago

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  4. Rollman, Bruce L.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  5. Rosner, Mitchell H.

    1. Training the Next Generation’s Nephrology Workforce
      Jeffrey S. Berns, David H. Ellison, Stuart L. Linas and Mitchell H. Rosner
      CJASN September 2014, 9 (9) 1639-1644; DOI: https://doi.org/10.2215/CJN.00560114

S

  1. Sánchez-Corral, Pilar

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  2. Sánchez Chinchilla, Daniel

    1. Complement Mutations in Diacylglycerol Kinase-ε–Associated Atypical Hemolytic Uremic Syndrome
      Daniel Sánchez Chinchilla, Sheila Pinto, Bernd Hoppe, Marta Adragna, Laura Lopez, Maria Luisa Justa Roldan, Antonia Peña, Margarita Lopez Trascasa, Pilar Sánchez-Corral and Santiago Rodríguez de Córdoba
      CJASN September 2014, 9 (9) 1611-1619; DOI: https://doi.org/10.2215/CJN.01640214

  3. Schaefer, Betti

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

  4. Schaefer, Franz

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

  5. Schaefer, Susanne

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

  6. Schmitt, Claus Peter

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

  7. Schneider, Louise I.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  8. Schneider, Michael F.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  9. Sevick, Mary Ann

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  10. Shavit, Linda

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  11. Shi, Shaolin

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  12. Shields, Anne Marie

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  13. Silberman, Shuli

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  14. Simonetti, Monica

    1. Risk of ESRD and Death in Patients with CKD Not Referred to a Nephrologist: A 7-Year Prospective Study
      Roberto Minutolo, Francesco Lapi, Paolo Chiodini, Monica Simonetti, Elisa Bianchini, Serena Pecchioli, Iacopo Cricelli, Claudio Cricelli, Gaetano Piccinocchi, Giuseppe Conte and Luca De Nicola
      CJASN September 2014, 9 (9) 1586-1593; DOI: https://doi.org/10.2215/CJN.10481013

  15. Singh, Karandeep

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  16. Sirich, Tammy L.

    1. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
      Tammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter and Timothy W. Meyer
      CJASN September 2014, 9 (9) 1603-1610; DOI: https://doi.org/10.2215/CJN.00490114

  17. Skversky, Amy L.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  18. Slotki, Itzchak

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  19. Smith, Richard J.H.

    1. Factors Influencing Treatment of Atypical Hemolytic Uremic Syndrome
      Carla M. Nester and Richard J.H. Smith
      CJASN September 2014, 9 (9) 1516-1518; DOI: https://doi.org/10.2215/CJN.07540714

  20. Smith, Rona

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  21. Sprague, Stuart M.

    1. A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3–4 CKD
      Daniel W. Coyne, Seth Goldberg, Mark Faber, Cybele Ghossein and Stuart M. Sprague
      CJASN September 2014, 9 (9) 1620-1626; DOI: https://doi.org/10.2215/CJN.10661013

  22. Szpirt, Wladimir

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

T

  1. Tauber, Rachel

    1. Preoperative Hemoglobin and Outcomes in Patients with CKD Undergoing Cardiac Surgery
      Linda Shavit, Sharbel Hitti, Shuli Silberman, Rachel Tauber, Ofer Merin, Meyer Lifschitz, Itzchak Slotki, Daniel Bitran and Daniel Fink
      CJASN September 2014, 9 (9) 1536-1544; DOI: https://doi.org/10.2215/CJN.00110114

  2. Tu, Yuanmao

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

U

  1. Ujszaszi, Akos

    1. Safety and Efficacy of Tandem Hemodialysis and Plasma Exchange in Children
      Betti Schaefer, Akos Ujszaszi, Susanne Schaefer, Karl Heinz Heckert, Franz Schaefer and Claus Peter Schmitt
      CJASN September 2014, 9 (9) 1563-1570; DOI: https://doi.org/10.2215/CJN.12581213

V

  1. Vaara, Suvi T.

    1. Timing of RRT Based on the Presence of Conventional Indications
      Suvi T. Vaara, Matti Reinikainen, Ron Wald, Sean M. Bagshaw, Ville Pettilä and The FINNAKI Study Group
      CJASN September 2014, 9 (9) 1577-1585; DOI: https://doi.org/10.2215/CJN.12691213

  2. van den Berg, Else

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813

  3. Vassalotti, Joseph

    1. Checklists as Computer Decision Support at the Point of Care: A Step Forward in the Recognition and Treatment of CKD by Primary Care Physicians
      Chester Fox and Joseph Vassalotti
      CJASN September 2014, 9 (9) 1505-1506; DOI: https://doi.org/10.2215/CJN.07270714

W

  1. Waikar, Sushrut S.

    1. Implementation of a CKD Checklist for Primary Care Providers
      Mallika L. Mendu, Louise I. Schneider, Ayal A. Aizer, Karandeep Singh, David E. Leaf, Thomas H. Lee and Sushrut S. Waikar
      CJASN September 2014, 9 (9) 1526-1535; DOI: https://doi.org/10.2215/CJN.01660214

  2. Wald, Ron

    1. Timing of RRT Based on the Presence of Conventional Indications
      Suvi T. Vaara, Matti Reinikainen, Ron Wald, Sean M. Bagshaw, Ville Pettilä and The FINNAKI Study Group
      CJASN September 2014, 9 (9) 1577-1585; DOI: https://doi.org/10.2215/CJN.12691213

  3. Walsh, Michael

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  4. Warady, Bradley A.

    1. Medication Adherence and Growth in Children with CKD
      Oleh M. Akchurin, Michael F. Schneider, Lucy Mulqueen, Ellen R. Brooks, Craig B. Langman, Larry A. Greenbaum, Susan L. Furth, Marva Moxey-Mims, Bradley A. Warady, Frederick J. Kaskel and Amy L. Skversky
      CJASN September 2014, 9 (9) 1519-1525; DOI: https://doi.org/10.2215/CJN.01150114

  5. Weisbord, Steven D.

    1. Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
      Steven D. Weisbord, Maria K. Mor, Mary Ann Sevick, Anne Marie Shields, Bruce L. Rollman, Paul M. Palevsky, Robert M. Arnold, Jamie A. Green and Michael J. Fine
      CJASN September 2014, 9 (9) 1594-1602; DOI: https://doi.org/10.2215/CJN.00220114

  6. Westman, Kerstin

    1. Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis
      Michael Walsh, Mikkel Faurschou, Annelies Berden, Oliver Flossmann, Ingeborg Bajema, Peter Hoglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey and David R.W. Jayne
      CJASN September 2014, 9 (9) 1571-1576; DOI: https://doi.org/10.2215/CJN.00100114

  7. Wilson, F. Perry

    1. A Policy of Preemption: The Timing of Renal Replacement Therapy in AKI
      F. Perry Wilson
      CJASN September 2014, 9 (9) 1510-1512; DOI: https://doi.org/10.2215/CJN.07210714

  8. Wish, Jay B.

    1. The Approval Process for Biosimilar Erythropoiesis-Stimulating Agents
      Jay B. Wish
      CJASN September 2014, 9 (9) 1645-1651; DOI: https://doi.org/10.2215/CJN.01770214

Z

  1. Zen, Ke

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  2. Zhang, Changming

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  3. Zhang, Wanfen

    1. Evaluation of MicroRNAs miR-196a, miR-30a-5P, and miR-490 as Biomarkers of Disease Activity among Patients with FSGS
      Wanfen Zhang, Changming Zhang, Huimei Chen, Limin Li, Yuanmao Tu, Chunbei Liu, Shaolin Shi, Ke Zen and Zhihong Liu
      CJASN September 2014, 9 (9) 1545-1552; DOI: https://doi.org/10.2215/CJN.11561113

  4. Zittema, Debbie

    1. Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
      Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
      CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813
Back to top

In this issue

View Selected Citations (0)